Mitotic chromosomal instability and cancer: mouse modelling of the human disease (original) (raw)

• Boveri, T. Über mehrpolige mitosen als mittel zur analyse des zellkerns. Verh. Phys. Med. Ges. Würzburg 35, 67–90 (1902).
  Google Scholar
• Boveri, T. Zur Frage der Entstehung Maligner Tumoren (Gustav Fischer, Jena, Germany, 1914).
  Google Scholar
• Ricke, R. M., van Ree, J. H. & van Deursen, J. M. Whole chromosome instability and cancer: a complex relationship. Trends Genet. 24, 457–466 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Artandi, S. E. et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641–645 (2000).
  Article CAS PubMed Google Scholar
• Garcia-Higuera, I. et al. Genomic stability and tumour suppression by the APC/C cofactor Cdh1. Nature Cell Biol. 10, 802–811 (2008).
  Article PubMed CAS Google Scholar
• Sotillo, R. et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11, 9–23 (2007). The authors show that inducible MAD2L1 overexpression leads to widespread W-CIN and S-CIN in murine fibroblasts and tumour formation when expressed in mice under a ubiquitous promoter.
  Article CAS PubMed Google Scholar
• Cleaver, J. E. Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nature Rev. Cancer 5, 564–573 (2005).
  Article CAS Google Scholar
• Kunkel, T. A. & Erie, D. A. DNA mismatch repair. Annu. Rev. Biochem. 74, 681–710 (2005).
  Article CAS PubMed Google Scholar
• Rustgi, A. K. The genetics of hereditary colon cancer. Genes Dev. 21, 2525–2538 (2007).
  Article CAS PubMed Google Scholar
• Verdun, R. E. & Karlseder, J. Replication and protection of telomeres. Nature 447, 924–931 (2007).
  Article CAS PubMed Google Scholar
• Lobrich, M. & Jeggo, P. A. The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Nature Rev. Cancer 7, 861–869 (2007).
  Article CAS Google Scholar
• Musacchio, A. & Salmon, E. D. The spindle-assembly checkpoint in space and time. Nature Rev. Mol. Cell Biol. 8, 379–393 (2007).
  Article CAS Google Scholar
• Nasmyth, K. How do so few control so many? Cell 120, 739–746 (2005).
  Article CAS PubMed Google Scholar
• Haering, C. H., Farcas, A. M., Arumugam, P., Metson, J. & Nasmyth, K. The cohesin ring concatenates sister DNA molecules. Nature 454, 297–301 (2008). Cohesin complexes are shown conclusively to topologically link sister chromatids.
  Article CAS PubMed Google Scholar
• Rieder, C. L., Cole, R. W., Khodjakov, A. & Sluder, G. The checkpoint delaying anaphase in response to chromosome monoorientation is mediated by an inhibitory signal produced by unattached kinetochores. J. Cell Biol. 130, 941–948 (1995).
  Article CAS PubMed Google Scholar
• Fang, G., Yu, H. & Kirschner, M. W. The checkpoint protein MAD2 and the mitotic regulator CDC20 form a ternary complex with the anaphase-promoting complex to control anaphase initiation. Genes Dev. 12, 1871–1883 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Shannon, K. B., Canman, J. C. & Salmon, E. D. Mad2 and BubR1 function in a single checkpoint pathway that responds to a loss of tension. Mol. Biol. Cell 13, 3706–3719 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Sudakin, V., Chan, G. K. & Yen, T. J. Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J. Cell Biol. 154, 925–936 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Wassmann, K. & Benezra, R. Mad2 transiently associates with an APC/p55Cdc complex during mitosis. Proc. Natl Acad. Sci. USA 95, 11193–11198 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Sudakin, V. et al. The cyclosome, a large complex containing cyclin-selective ubiquitin ligase activity, targets cyclins for destruction at the end of mitosis. Mol. Biol. Cell 6, 185–197 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• De Antoni, A. et al. The Mad1/Mad2 complex as a template for Mad2 activation in the spindle assembly checkpoint. Curr. Biol. 15, 214–225 (2005). In vitro evidence for the MAD2 template model, which suggests an amplification mechanism by which kinetochore-bound MAD2 inhibits the APC/C.
  Article CAS PubMed Google Scholar
• Varetti, G. & Musacchio, A. The spindle assembly checkpoint. Curr. Biol. 18, R591–R595 (2008).
  Article CAS PubMed Google Scholar
• Malureanu, L. A. et al. BubR1 N terminus acts as a soluble inhibitor of cyclin B degradation by APC/C(Cdc20) in interphase. Dev. Cell 16, 118–131 (2009). The authors show that BUBR1 function is dispensable at the kinetochores and is only required in the MCC to inhibit the APC/C.
  Article CAS PubMed PubMed Central Google Scholar
• Braunstein, I., Miniowitz, S., Moshe, Y. & Hershko, A. Inhibitory factors associated with anaphase-promoting complex/cyclosome in mitotic checkpoint. Proc. Natl Acad. Sci. USA 104, 4870–4875 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Herzog, F. et al. Structure of the anaphase-promoting complex/cyclosome interacting with a mitotic checkpoint complex. Science 323, 1477–1481 (2009). The authors provide structural evidence for the MCC and suggest a mechanism by which it inhibits the APC/C.
  Article CAS PubMed PubMed Central Google Scholar
• Nilsson, J., Yekezare, M., Minshull, J. & Pines, J. The APC/C maintains the spindle assembly checkpoint by targeting Cdc20 for destruction. Nature Cell Biol. 10, 1411–1420 (2008). CDC20 ubiquitylation by the APC/C during an active checkpoint is shown to be required to prevent satisfaction of the mitotic checkpoint.
  Article CAS PubMed Google Scholar
• Wassmann, K., Liberal, V. & Benezra, R. Mad2 phosphorylation regulates its association with Mad1 and the APC/C. EMBO J. 22, 797–806 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Choi, E. et al. BubR1 acetylation at prometaphase is required for modulating APC/C activity and timing of mitosis. EMBO J. 28, 2077–2089 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Reddy, S. K., Rape, M., Margansky, W. A. & Kirschner, M. W. Ubiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation. Nature 446, 921–925 (2007).
  Article CAS PubMed Google Scholar
• Stegmeier, F. et al. Anaphase initiation is regulated by antagonistic ubiquitination and deubiquitination activities. Nature 446, 876–881 (2007).
  Article CAS PubMed Google Scholar
• Land, H., Parada, L. F. & Weinberg, R. A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304, 596–602 (1983).
  Article CAS PubMed Google Scholar
• Perucho, M. et al. Human-tumor-derived cell lines contain common and different transforming genes. Cell 27, 467–476 (1981).
  Article CAS PubMed Google Scholar
• Chang, E. H., Furth, M. E., Scolnick, E. M. & Lowy, D. R. Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus. Nature 297, 479–483 (1982).
  Article CAS PubMed Google Scholar
• Goldfarb, M., Shimizu, K., Perucho, M. & Wigler, M. Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells. Nature 296, 404–409 (1982).
  Article CAS PubMed Google Scholar
• Land, H., Parada, L. F. & Weinberg, R. A. Cellular oncogenes and multistep carcinogenesis. Science 222, 771–778 (1983).
  Article CAS PubMed Google Scholar
• Shih, C., Padhy, L. C., Murray, M. & Weinberg, R. A. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature 290, 261–264 (1981).
  Article CAS PubMed Google Scholar
• Pei, L. & Melmed, S. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol. Endocrinol. 11, 433–441 (1997).
  Article CAS PubMed Google Scholar
• Vader, G. & Lens, S. M. The Aurora kinase family in cell division and cancer. Biochim. Biophys. Acta 1786, 60–72 (2008).
  CAS PubMed Google Scholar
• Katayama, H., Brinkley, W. R. & Sen, S. The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev. 22, 451–464 (2003).
  Article PubMed Google Scholar
• Zhang, D. et al. Cre–loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models. Oncogene 23, 8720–8730 (2004).
  Article CAS PubMed Google Scholar
• Lee, S. H., Sterling, H., Burlingame, A. & McCormick, F. Tpr directly binds to Mad1 and Mad2 and is important for the Mad1–Mad2-mediated mitotic spindle checkpoint. Genes Dev. 22, 2926–2931 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Dawlaty, M. M. et al. Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIα. Cell 133, 103–115 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Bernal, J. A. et al. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nature Genet. 32, 306–311 (2002).
  Article CAS PubMed Google Scholar
• Fang, Y. et al. BubR1 is involved in regulation of DNA damage responses. Oncogene 25, 3598–3605 (2006).
  Article CAS PubMed Google Scholar
• Hein, J. et al. Simian virus 40 large T antigen disrupts genome integrity and activates a DNA damage response via Bub1 binding. J. Virol. 83, 117–127 (2009).
  Article CAS PubMed Google Scholar
• Carter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N. & Szallasi, Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nature Genet. 38, 1043–1048 (2006). Transcriptional analysis of human aneuploid tumours reveals a signature of CIN that has prognostic power independent of its relationship to cell cycle progression.
  Article CAS PubMed Google Scholar
• Kronenwett, U. et al. Improved grading of breast adenocarcinomas based on genomic instability. Cancer Res. 64, 904–909 (2004).
  Article CAS PubMed Google Scholar
• Rhodes, D. R. et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6, 1–6 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Dobles, M., Liberal, V., Scott, M. L., Benezra, R. & Sorger, P. K. Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell 101, 635–645 (2000).
  Article CAS PubMed Google Scholar
• Baker, D. J. et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature Genet. 36, 744–749 (2004).
  Article CAS PubMed Google Scholar
• Dai, W. et al. Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency. Cancer Res. 64, 440–445 (2004).
  Article CAS PubMed Google Scholar
• Babu, J. R. et al. Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J. Cell Biol. 160, 341–353 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Kalitsis, P., Earle, E., Fowler, K. J. & Choo, K. H. Bub3 gene disruption in mice reveals essential mitotic spindle checkpoint function during early embryogenesis. Genes Dev. 14, 2277–2282 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Jeganathan, K., Malureanu, L., Baker, D. J., Abraham, S. C. & van Deursen, J. M. Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis. J. Cell Biol. 179, 255–267 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Weaver, B. A., Silk, A. D., Montagna, C., Verdier-Pinard, P. & Cleveland, D. W. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11, 25–36 (2006).
  Article PubMed CAS Google Scholar
• Li, M., Fang, X., Wei, Z., York, J. P. & Zhang, P. Loss of spindle assembly checkpoint-mediated inhibition of Cdc20 promotes tumorigenesis in mice. J. Cell Biol. 185, 983–994 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Pérez de Castro, I., de Cárcer, G. & Malumbres, M. A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy. Carcinogenesis 28, 899–912 (2007).
  Article PubMed CAS Google Scholar
• Perera, D. et al. Bub1 maintains centromeric cohesion by activation of the spindle checkpoint. Dev. Cell 13, 566–579 (2007).
  Article CAS PubMed Google Scholar
• Jeong, S. J. et al. Transcriptional abnormality of the hsMAD2 mitotic checkpoint gene is a potential link to hepatocellular carcinogenesis. Cancer Res. 64, 8666–8673 (2004).
  Article CAS PubMed Google Scholar
• Sze, K. M., Ching, Y. P., Jin, D. Y. & Ng, I. O. Association of MAD2 expression with mitotic checkpoint competence in hepatoma cells. J. Biomed. Sci. 11, 920–927 (2004).
  Article CAS PubMed Google Scholar
• Wang, X. et al. Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. Cancer Res. 62, 1662–1668 (2002).
  CAS PubMed Google Scholar
• Wang, X. et al. Correlation of defective mitotic checkpoint with aberrantly reduced expression of MAD2 protein in nasopharyngeal carcinoma cells. Carcinogenesis 21, 2293–2297 (2000).
  Article CAS PubMed Google Scholar
• Ren, B. et al. E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints. Genes Dev. 16, 245–56 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Hanks, S. et al. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nature Genet. 36, 1159 (2004).
  Article CAS PubMed Google Scholar
• Gascoigne, K. E. & Taylor, S. S. Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 14, 111–122 (2008).
  Article CAS PubMed Google Scholar
• Tighe, A., Johnson, V. L., Albertella, M. & Taylor, S. S. Aneuploid colon cancer cells have a robust spindle checkpoint. EMBO Rep. 2, 609–614 (2001). References 65 and 66 provide evidence for a strong mitotic checkpoint in tumour cell lines and provide a mechanistic model for mitotic slippage.
  Article CAS PubMed PubMed Central Google Scholar
• Rhodes, D. R. et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9, 166–180 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Hernando, E. et al. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430, 797–802 (2004).
  Article CAS PubMed Google Scholar
• Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instability in colorectal cancers. Nature 386, 623–627 (1997).
  Article CAS PubMed Google Scholar
• Nicholson, J. M. & Duesberg, P. On the karyotypic origin and evolution of cancer cells. Cancer Genet. Cytogenet. 194, 96–110 (2009).
  Article CAS PubMed Google Scholar
• Diaz-Rodriguez, E., Sotillo, R., Schvartzman, J. M. & Benezra, R. Hec1 overexpression hyperactivates the mitotic checkpoint and induces tumor formation in vivo. Proc. Natl Acad. Sci. USA 105, 16719–16724 (2008). The authors show that overexpression of HEC1, an essential component of the kinetochore complex, leads to mitotic checkpoint overactivation, CIN and tumorigenesis in mice.
  Article CAS PubMed PubMed Central Google Scholar
• Thompson, S. L. & Compton, D. A. Examining the link between chromosomal instability and aneuploidy in human cells. J. Cell Biol. 180, 665–672 (2008). Chemical overactivation of the mitotic checkpoint is shown to generate lagging chromosomes and aneuploidy, which are selected against in non-tumorigenic cell lines.
  Article CAS PubMed PubMed Central Google Scholar
• Rieder, C. L. & Maiato, H. Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev. Cell 7, 637–651 (2004).
  Article CAS PubMed Google Scholar
• Brito, D. A. & Rieder, C. L. Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Curr. Biol. 16, 1194–1200 (2006). Mitotic slippage is shown to occur in an APC/C dependent manner in the presence of checkpoint activity.
  Article CAS PubMed PubMed Central Google Scholar
• Iovino, F., Lentini, L., Amato, A. & Di Leonardo, A. RB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts. Mol. Cancer 5, 38 (2006).
  Article PubMed PubMed Central CAS Google Scholar
• Lentini, L., Iovino, F., Amato, A. & Di Leonardo, A. Centrosome amplification induced by hydroxyurea leads to aneuploidy in pRB deficient human and mouse fibroblasts. Cancer Lett. 238, 153–160 (2006).
  Article CAS PubMed Google Scholar
• Lentini, L., Pipitone, L. & Di Leonardo, A. Functional inactivation of pRB results in aneuploid mammalian cells after release from a mitotic block. Neoplasia 4, 380–387 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Mayhew, C. N. et al. RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis. Gastroenterology 133, 976–984 (2007).
  Article CAS PubMed Google Scholar
• Zheng, L., Flesken-Nikitin, A., Chen, P. L. & Lee, W. H. Deficiency of retinoblastoma gene in mouse embryonic stem cells leads to genetic instability. Cancer Res. 62, 2498–2502 (2002).
  CAS PubMed Google Scholar
• Quintyne, N. J., Reing, J. E., Hoffelder, D. R., Gollin, S. M. & Saunders, W. S. Spindle multipolarity is prevented by centrosomal clustering. Science 307, 127–129 (2005).
  Article CAS PubMed Google Scholar
• Kwon, M. et al. Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes Dev. 22, 2189–2203 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Silkworth, W. T., Nardi, I. K., Scholl, L. M. & Cimini, D. Multipolar spindle pole coalescence is a major source of kinetochore mis-attachment and chromosome mis-segregation in cancer cells. PLoS ONE 4, e6564 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Ganem, N. J., Godinho, S. A. & Pellman, D. A mechanism linking extra centrosomes to chromosomal instability. Nature 460, 278–282 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Iwanaga, Y. et al. Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice. Cancer Res. 67, 160–166 (2007).
  Article CAS PubMed Google Scholar
• Ko, M. A. et al. Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis. Nature Genet. 37, 883–888 (2005).
  Article CAS PubMed Google Scholar
• Holland, A. J. & Cleveland, D. W. Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nature Rev. Mol. Cell Biol. 10, 478–487 (2009).
  Article CAS Google Scholar
• Wang, X. et al. Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation. Oncogene 25, 7148–7158 (2006).
  Article CAS PubMed Google Scholar
• Swanton, C. et al. Chromosomal instability determines taxane response. Proc. Natl Acad. Sci. USA 106, 8671–8676 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Malumbres, M. & Barbacid, M. RAS oncogenes: the first 30 years. Nature Rev. Cancer 3, 459–465 (2003).
  Article CAS Google Scholar
• Meyer, N. & Penn, L. Z. Reflecting on 25 years with MYC. Nature Rev. Cancer 8, 976–990 (2008).
  Article CAS Google Scholar
• Donehower, L. A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215–221 (1992).
  Article CAS PubMed Google Scholar
• Jacks, T. et al. Effects of an Rb mutation in the mouse. Nature 359, 295–300 (1992).
  Article CAS PubMed Google Scholar
• Williams, B. R. et al. Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 322, 703–709 (2008). Trisomy generated by Robertsonian translocations is shown to be detrimental to the viability of primary cell lines.
  Article CAS PubMed PubMed Central Google Scholar
• Gonzalo, S. et al. Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nature Cell Biol. 7, 420–428 (2005).
  Article CAS PubMed Google Scholar
• Rao, C. V. et al. Colonic tumorigenesis in BubR1 +/− Apc Min/+ compound mutant mice is linked to premature separation of sister chromatids and enhanced genomic instability. Proc. Natl Acad. Sci. USA 102, 4365–4370 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Jordan, M. A. & Wilson, L. Microtubules as a target for anticancer drugs. Nature Rev. Cancer 4, 253–265 (2004).
  CAS Google Scholar
• Huang, H. C., Shi, J., Orth, J. D. & Mitchison, T. J. Evidence that mitotic exit is a better cancer therapeutic target than spindle assembly. Cancer Cell 16, 347–358 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Weinert, T. A. & Hartwell, L. H. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241, 317–322 (1988).
  Article CAS PubMed Google Scholar
• Weinert, T. & Hartwell, L. Control of G2 delay by the rad9 gene of Saccharomyces cerevisiae. J. Cell Sci. 12 (Suppl.), 145–148 (1989).
  Article CAS Google Scholar
• Li, R. & Murray, A. Feedback control of mitosis in budding yeast. Cell 66, 519–531 (1991).
  Article CAS PubMed Google Scholar
• Hoyt, M. A., Totis, L. & Roberts, B. T. S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell 66, 507–517 (1991).
  Article CAS PubMed Google Scholar
• Li, Y. & Benezra, R. Identification of a human mitotic checkpoint gene: hsMAD2. Science 274, 246–248 (1996). References 101 and 102 were the first to identify mitotic checkpoint genes.
  Article CAS PubMed Google Scholar
• Kops, G. J., Foltz, D. R. & Cleveland, D. W. Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint. Proc. Natl Acad. Sci. USA 101, 8699–8704 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Michel, L. S. et al. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409, 355–359 (2001). References 103 and 104 show that, unlike the case for the G2/M DNA damage checkpoint and the mitotic checkpoint in budding yeast, the mitotic checkpoint in vertebrates is essential for cell viability.
  Article CAS PubMed Google Scholar
• Meraldi, P., Draviam, V. M. & Sorger, P. K. Timing and checkpoints in the regulation of mitotic progression. Dev. Cell 7, 45–60 (2004).
  Article CAS PubMed Google Scholar
• Zhou, H. et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nature Genet. 20, 189–193 (1998).
  Article CAS PubMed Google Scholar
• Sen, S. et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J. Natl Cancer Inst. 94, 1320–1329 (2002).
  Article CAS PubMed Google Scholar
• Bischoff, J. R. et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 17, 3052–3065 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Miyoshi, Y., Iwao, K., Egawa, C. & Noguchi, S. Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers. Int. J. Cancer 92, 370–373 (2001).
  Article CAS PubMed Google Scholar
• Baba, Y. et al. Aurora-A expression is independently associated with chromosomal instability in colorectal cancer. Neoplasia 11, 418–4125 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Gritsko, T. M. et al. Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin. Cancer Res. 9, 1420–1426 (2003).
  CAS PubMed Google Scholar
• Ablikim, M. et al. Observation of Y(2175) in J/σπ psi →etaphif0 (980). Phys. Rev. Lett. 100, 102003 (2008).
  Article CAS PubMed Google Scholar
• Sakakura, C. et al. Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br. J. Cancer 84, 824–831 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Twu, N. F. et al. Expression of Aurora kinase A and B in normal and malignant cervical tissue: high Aurora A kinase expression in squamous cervical cancer. Eur. J. Obstet. Gynecol. Reprod. Biol. 142, 57–63 (2009).
  Article CAS PubMed Google Scholar
• Reiter, R. et al. Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma. Clin. Cancer Res. 12, 5136–5141 (2006).
  Article CAS PubMed Google Scholar
• Lu, L. Y. et al. Aurora A is essential for early embryonic development and tumor suppression. J. Biol. Chem. 283, 31785–31790 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Cowley, D. O. et al. Aurora-A kinase is essential for bipolar spindle formation and early development. Mol. Cell Biol. 29, 1059–1071 (2009).
  Article CAS PubMed Google Scholar
• Araki, K., Nozaki, K., Ueba, T., Tatsuka, M. & Hashimoto, N. High expression of Aurora-B/Aurora and Ipll-like midbody-associated protein (AIM-1) in astrocytomas. J. Neurooncol. 67, 53–64 (2004).
  Article PubMed Google Scholar
• Chieffi, P. et al. Aurora B expression in normal testis and seminomas. J. Endocrinol. 181, 263–270 (2004).
  Article CAS PubMed Google Scholar
• Gibson, S. E., Zeng, W. F., Weil, R. J. & Prayson, R. A. Aurora B kinase expression in ependymal neoplasms. Appl. Immunohistochem. Mol. Morphol. 16, 274–278 (2008).
  Article CAS PubMed Google Scholar
• Chieffi, P. et al. Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation. Prostate 66, 326–333 (2006).
  Article CAS PubMed Google Scholar
• Smith, S. L. et al. Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability. Br. J. Cancer 93, 719–729 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Tanaka, S. et al. Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy. Br. J. Surg. 95, 611–619 (2008).
  Article CAS PubMed Google Scholar
• Nguyen, H. G. et al. Deregulated Aurora-B induced tetraploidy promotes tumorigenesis. FASEB J. 23, 2741–2748 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Gemma, A. et al. Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer. Genes Chromosomes Cancer 29, 213–218 (2000).
  Article CAS PubMed Google Scholar
• Hempen, P. M., Kurpad, H., Calhoun, E. S., Abraham, S. & Kern, S. E. A double missense variation of the BUB1 gene and a defective mitotic spindle checkpoint in the pancreatic cancer cell line Hs766T. Hum. Mutat. 21, 445 (2003).
  Article PubMed CAS Google Scholar
• Shichiri, M., Yoshinaga, K., Hisatomi, H., Sugihara, K. & Hirata, Y. Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. Cancer Res. 62, 713–717 (2002).
  Google Scholar
• Lin, S. F. et al. Expression of hBUB1 in acute myeloid leukemia. Leuk. Lymphoma 43, 385–391 (2002).
  Article CAS PubMed Google Scholar
• Yuan, B. et al. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin. Cancer Res. 12, 405–410 (2006).
  Article CAS PubMed Google Scholar
• Moreno-Bueno, G. et al. Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas. Cancer Res. 63, 5697–5702 (2003).
  CAS PubMed Google Scholar
• Grabsch, H. et al. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer — association with tumour cell proliferation. J. Pathol. 200, 16–22 (2003).
  Article CAS PubMed Google Scholar
• Pinto, M. et al. Overexpression of the mitotic checkpoint genes BUB1 and BUBR1 is associated with genomic complexity in clear cell kidney carcinomas. Cell Oncol. 30, 389–395 (2008).
  CAS PubMed PubMed Central Google Scholar
• Wada, N. et al. Overexpression of the mitotic spindle assembly checkpoint genes hBUB1, hBUBR1 and hMAD2 in thyroid carcinomas with aggressive nature. Anticancer Res. 28, 139–144 (2008).
  CAS PubMed Google Scholar
• Cahill, D. P. et al. Mutations of mitotic checkpoint genes in human cancers. Nature 392, 300–303 (1998).
  Article CAS PubMed Google Scholar
• Schliekelman, M. et al. Impaired Bub1 function in vivo compromises tension-dependent checkpoint function leading to aneuploidy and tumorigenesis. Cancer Res. 69, 45–54 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Baker, D. J. et al. Early aging-associated phenotypes in Bub3/Rae1 haploinsufficient mice. J. Cell Biol. 172, 529–540 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Kalitsis, P. et al. Increased chromosome instability but not cancer predisposition in haploinsufficient Bub3 mice. Genes Chromosomes Cancer 44, 29–36 (2005).
  Article CAS PubMed Google Scholar
• Mondal, G. et al. Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer. Carcinogenesis 28, 81–92 (2007).
  Article CAS PubMed Google Scholar
• Li, D. et al. Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin. Cancer Res. 9, 991–997 (2003).
  CAS PubMed Google Scholar
• Kim, J. M. et al. Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells. Clin. Cancer Res. 11, 473–482 (2005).
  PubMed Google Scholar
• Ouellet, V. et al. Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer. Int. J. Cancer 119, 599–607 (2006).
  Article CAS PubMed Google Scholar
• Marucci, G. et al. Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20. Virchows Arch. 453, 599–609 (2008).
  Article CAS PubMed Google Scholar
• Singhal, S. et al. Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profiling. Cancer Biol. Ther. 2, 291–298 (2003).
  Article CAS PubMed Google Scholar
• Fujita, T., Liu, W., Doihara, H. & Wan, Y. Regulation of Skp2–p27 axis by the Cdh1/anaphase-promoting complex pathway in colorectal tumorigenesis. Am. J. Pathol. 173, 217–228 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Lehman, N. L. et al. Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors. Am. J. Pathol. 170, 1793–1805 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Wierinckx, A. et al. A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors. Endocr. Relat. Cancer 14, 887–900 (2007).
  Article CAS PubMed Google Scholar
• Weaver, B. A. & Cleveland, D. W. Aneuploidy: instigator and inhibitor of tumorigenesis. Cancer Res. 67, 10103–10105 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Weaver, B. A., Silk, A. D., Montagna, C., Verdier-Pinard, P. & Cleveland, D. W. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11, 25–36 (2007).
  Article CAS PubMed Google Scholar
• Wikman, H. et al. Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 21, 5804–5813 (2002).
  Article CAS PubMed Google Scholar
• Kettunen, E. et al. Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer. Cancer Genet. Cytogenet. 149, 98–106 (2004).
  Article CAS PubMed Google Scholar
• Soria, J. C. et al. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res. 60, 4000–4004 (2000).
  CAS PubMed Google Scholar
• Koon, N. et al. Molecular targets for tumour progression in gastrointestinal stromal tumours. Gut 53, 235–240 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Takeno, S. et al. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer 94, 2874–2881 (2002).
  Article CAS PubMed Google Scholar
• Yoshida, T., Tanaka, S., Mogi, A., Shitara, Y. & Kuwano, H. The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer. Ann. Oncol. 15, 252–256 (2004).
  Article CAS PubMed Google Scholar
• Ikuerowo, S. O. et al. Alteration of subcellular and cellular expression patterns of cyclin B1 in renal cell carcinoma is significantly related to clinical progression and survival of patients. Int. J. Cancer 119, 867–874 (2006).
  Article CAS PubMed Google Scholar
• Agarwal, R. et al. Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer. Clin. Cancer Res. 15, 3654–3662 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Aaltonen, K. et al. High cyclin B1 expression is associated with poor survival in breast cancer. Br. J. Cancer 100, 1055–1060 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Brandeis, M. et al. Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero. Proc. Natl Acad. Sci. USA 95, 4344–4349 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Hayama, S. et al. Activation of CDCA1–KNTC2, members of centromere protein complex, involved in pulmonary carcinogenesis. Cancer Res. 66, 10339–10348 (2006).
  Article CAS PubMed Google Scholar
• Perez de Castro, I., de Carcer, G. & Malumbres, M. A census of mitotic cancer genes: new insights into tumor cell biology and cancer therapy. Carcinogenesis 28, 899–912 (2007).
  Article CAS PubMed Google Scholar
• Nomoto, S. et al. Search for in vivo somatic mutations in the mitotic checkpoint gene, hMAD1, in human lung cancers. Oncogene 18, 7180–7183 (1999).
  Article CAS PubMed Google Scholar
• Tsukasaki, K. et al. Mutations in the mitotic check point gene, MAD1L1, in human cancers. Oncogene 20, 3301–3305 (2001).
  Article CAS PubMed Google Scholar
• Nishigaki, R. et al. Proteomic identification of differentially-expressed genes in human gastric carcinomas. Proteomics 5, 3205–3213 (2005).
  Article CAS PubMed Google Scholar
• Han, S. et al. Clinical implication of altered expression of Mad1 protein in human breast carcinoma. Cancer 88, 1623–1632 (2000).
  Article CAS PubMed Google Scholar
• Nam, C. W. et al. Mitotic checkpoint gene MAD1 in hepatocellular carcinoma is associated with tumor recurrence after surgical resection. J. Surg. Oncol. 97, 567–571 (2008).
  Article PubMed Google Scholar
• Chi, Y. H., Ward, J. M., Cheng, L. I., Yasunaga, J. & Jeang, K. T. Spindle assembly checkpoint and p53 deficiencies cooperate for tumorigenesis in mice. Int. J. Cancer 124, 1483–1489 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Hernando, E. et al. Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer. Int. J. Cancer 95, 223–227 (2001).
  Article CAS PubMed Google Scholar
• Percy, M. J. et al. Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells. Genes Chromosomes Cancer 29, 356–362 (2000).
  Article CAS PubMed Google Scholar
• Alizadeh, A. A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–511 (2000).
  Article CAS PubMed Google Scholar
• Chen, X. et al. Gene expression patterns in human liver cancers. Mol. Biol. Cell 13, 1929–1939 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Garber, M. E. et al. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl Acad. Sci. USA 98, 13784–13789 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Heighway, J. et al. Expression profiling of primary non-small cell lung cancer for target identification. Oncogene 21, 7749–7763 (2002).
  Article CAS PubMed Google Scholar
• Hisaoka, M., Matsuyama, A. & Hashimoto, H. Aberrant MAD2 expression in soft-tissue sarcoma. Pathol. Int. 58, 329–333 (2008).
  Article PubMed Google Scholar
• Wang, L. et al. MAD2 as a key component of mitotic checkpoint: a probable prognostic factor for gastric cancer. Am. J. Clin. Pathol. 131, 793–801 (2009).
  Article CAS PubMed Google Scholar
• Rimkus, C. et al. Expression of the mitotic checkpoint gene MAD2L2 has prognostic significance in colon cancer. Int. J. Cancer 120, 207–211 (2007).
  Article CAS PubMed Google Scholar
• Grutzmann, R. et al. Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays. Neoplasia 6, 611–622 (2004).
  Article PubMed PubMed Central CAS Google Scholar
• Saez, C. et al. hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias. Oncogene 18, 5473–5476 (1999).
  Article CAS PubMed Google Scholar
• Honda, S. et al. A role for the pituitary tumor-transforming gene in the genesis and progression of non-small cell lung carcinomas. Anticancer Res. 23, 3775–3782 (2003).
  CAS PubMed Google Scholar
• Genkai, N., Homma, J., Sano, M., Tanaka, R. & Yamanaka, R. Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patients. Oncol. Rep. 15, 1569–1574 (2006).
  CAS PubMed Google Scholar
• Fujii, T. et al. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis. Hepatology 43, 1267–1275 (2006).
  Article CAS PubMed Google Scholar
• Su, M. C., Hsu, H. C., Liu, Y. J. & Jeng, Y. M. Overexpression of pituitary tumor-transforming gene-1 in hepatocellular carcinoma. Hepatogastroenterology 53, 262–265 (2006).
  CAS PubMed Google Scholar
• Zhu, X. et al. Significance of pituitary tumor transforming gene 1 (PTTG1) in prostate cancer. Anticancer Res. 26, 1253–1259 (2006).
  CAS PubMed Google Scholar
• Puri, R., Tousson, A., Chen, L. & Kakar, S. S. Molecular cloning of pituitary tumor transforming gene 1 from ovarian tumors and its expression in tumors. Cancer Lett. 163, 131–139 (2001).
  Article CAS PubMed Google Scholar
• Heaney, A. P. et al. Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet 355, 716–719 (2000).
  Article CAS PubMed Google Scholar
• Liang, H. S. et al. Comparative analysis of protein expression in differentiated thyroid tumours: a multicentre study. J. Int. Med. Res. 37, 927–938 (2009).
  Article CAS PubMed Google Scholar
• Chiriva-Internati, M. et al. The pituitary tumor transforming gene 1 (PTTG-1): an immunological target for multiple myeloma. J. Transl. Med. 6, 15 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Ramaswamy, S., Ross, K. N., Lander, E. S. & Golub, T. R. A molecular signature of metastasis in primary solid tumors. Nature Genet. 33, 49–54 (2003).
  Article CAS PubMed Google Scholar
• Yan, S. et al. PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma. Cancer Res. 69, 3283–3290 (2009).
  Article CAS PubMed Google Scholar
• Wang, Z., Yu, R. & Melmed, S. Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. Mol. Endocrinol. 15, 1870–1879 (2001).
  Article CAS PubMed Google Scholar
• Chesnokova, V., Kovacs, K., Castro, A. V., Zonis, S. & Melmed, S. Pituitary hypoplasia in Pttg −/− mice is protective for Rb +/− pituitary tumorigenesis. Mol. Endocrinol. 19, 2371–2379 (2005).
  Article CAS PubMed Google Scholar
• Abbud, R. A. et al. Early multipotential pituitary focal hyperplasia in the α-subunit of glycoprotein hormone-driven pituitary tumor-transforming gene transgenic mice. Mol. Endocrinol. 19, 1383–1391 (2005).
  Article CAS PubMed Google Scholar
• Donangelo, I. et al. Pituitary tumor transforming gene overexpression facilitates pituitary tumor development. Endocrinology 147, 4781–4791 (2006).
  Article CAS PubMed Google Scholar
• Simizu, S. & Osada, H. Mutations in the Plk gene lead to instability of Plk protein in human tumour cell lines. Nature Cell Biol. 2, 852–854 (2000).
  Article CAS PubMed Google Scholar
• Tokumitsu, Y. et al. Prognostic significance of polo-like kinase expression in esophageal carcinoma. Int. J. Oncol. 15, 687–692 (1999).
  CAS PubMed Google Scholar
• Wolf, G. et al. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Oncogene 14, 543–549 (1997).
  Article CAS PubMed Google Scholar
• Macmillan, J. C., Hudson, J. W., Bull., S., Dennis, J. W. & Swallow, C. J. Comparative expression of the mitotic regulators SAK and PLK in colorectal cancer. Ann. Surg. Oncol. 8, 729–740 (2001).
  Article CAS PubMed Google Scholar
• Nappi, T. C. et al. Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma. Cancer Res. 69, 1916–1923 (2009).
  Article CAS PubMed Google Scholar
• Lu, L. Y. et al. Polo-like kinase 1 is essential for early embryonic development and tumor suppression. Mol. Cell Biol. 28, 6870–6876 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Jackson, J. R., Patrick, D. R., Dar, M. M. & Huang, P. S. Targeted anti-mitotic therapies: can we improve on tubulin agents? Nature Rev. Cancer 7, 107–117 (2007).
  Article CAS Google Scholar
• Sotillo, R., Schvartzman, J. M., Socci, N. D. & Benezra, R. Mad2-induced chromosome instability leads to lung tumor relapse after oncogene withdrawal. Nature (in the press).